J.P. Morgan Securities LLC Allergan plc 38.5(b) (5053M)
11 May 2020 - 8:52PM
UK Regulatory
TIDM0Y7T
RNS Number : 5053M
J.P. Morgan Securities LLC
11 May 2020
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS,
OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal J.P Morgan Securities LLC
trader
Company dealt in Allergan plc
=========================
Class of relevant security Ordinary Share
to which the dealings
being disclosed relate
(Note 1)
=========================
Date of dealing 8 May 2020
=========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 2)
Long Short
Number (%) Number (%)
========= ====== =========== ======
10,400,644 3,406,704
(1) Relevant securities 3.16 1.03
================= ===================
(2) Derivatives (other 4,225,421
than options) 4,086,479 1.24 1.28
================= ===================
(3) Options and agreements
to purchase/sell 305,000 0.09 0 0.00
================= ===================
14,792,123 7,632,125
Total 4.49 2.31
================= ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 2)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap28
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 4)
Purchases 4,309,711 192.1350 USD
200 192.3100 USD
23 192.5900 USD
1 192.6600 USD
206 192.8354 USD
500 192.8580 USD
526 192.9900 USD
500 192.9950 USD
41,748 193.0094 USD
884 193.0100 USD
1,849,037 193.0200 USD
400 193.0550 USD
100 193.1100 USD
Sales 1 192.1000 USD
400 192.3100 USD
800 192.3750 USD
1,765 192.3978 USD
31 192.4100 USD
15 192.4433 USD
100 192.4600 USD
300 192.4667 USD
20 192.4710 USD
1,892 192.5100 USD
2 192.6350 USD
1 192.6600 USD
5 192.6700 USD
7 192.7057 USD
3 192.7100 USD
2 192.7350 USD
1 192.7400 USD
26 192.9900 USD
500 192.9950 USD
70,356 193.0200 USD
600 193.5002 USD
106 193.5006 USD
==================================== ===================
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, securities unit
e.g. CFD (Note 5) (Note 6) (USD)
(Note 4)
Equity Swaps Long 200 192.3100
7,229 193.0200
Short 500 192.9950
====================== =================== ==========
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 4)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
4)
(d) Other dealings (including transactions in respect of new
securities) (Note 3)
Nature of transaction Details Price per unit
(Note 7) (if applicable)
(Note 4)
Ap29
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant
securities under any
option referred to
on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced.
If none, this should be stated.
Is a Supplemental Form 38.5(b) attached? (Note 8) YES
Date of disclosure 11 May 2020
Contact name Alwyn Basch
=============================
Telephone number 020 7742 7407
=============================
Name of offeree/offeror Allergan plc
with which connected
=============================
Nature of connection (Note Financial Advisor to Allergan
9) plc
=============================
Ap31
SUPPLEMENTAL FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)
Product Written Number of Exercise Type, e.g. Expiry
name, or purchased relevant price American, date
e.g. call securities (Note European
option to which 2) etc.
the option
or derivative
relates
Put Option Written 300,000 150.00 American 19JUN20
Put Option Written 5,000 140.00 American 19JUN20
============== =============== ========= =========== ========
Notes
1. Where there are open option positions or open derivative
positions (except for CFDs), full details should be given. Full
details of any existing agreements to purchase or to sell must also
be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosur e requirements, see Rules 8 and
38.5 of the Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEKZGMKGMGGGZM
(END) Dow Jones Newswires
May 11, 2020 06:52 ET (10:52 GMT)
Allergan (LSE:0Y7T)
Historical Stock Chart
From Apr 2024 to May 2024
Allergan (LSE:0Y7T)
Historical Stock Chart
From May 2023 to May 2024
